Following the Money, From August 2025 to Now
The pattern here is worth laying out in full, because each step tells you something about how quickly this sector's fortunes have turned. 1789 Capital first disclosed a "double-digit millions" investment in August 2025, at a moment when Polymarket was still operating in genuine US regulatory limbo, without the CFTC-licensed exchange that would eventually clear its path back into the American market. The fund built that position to roughly $200 million over the following year. This week's $300 million addition, reported first by Bloomberg and corroborated by the Wall Street Journal and TechCrunch, pushes total disclosed commitment to about $500 million and values the company 40% higher than the roughly $15 billion mark it hit just months ago.
Polymarket isn't relying on 1789 Capital alone, either. Intercontinental Exchange — the parent company of the New York Stock Exchange — remains the platform's largest single shareholder, holding around 22% of equity after committing up to $2 billion in October 2025 and adding another $600 million this past March. ICE's own accounting carried that position at roughly $2 billion as of June 30, representing about 14% of the company on a fully diluted basis. Having the NYSE's parent company as your anchor investor is, on its own, a meaningfully different credibility signal than a venture fund with a politically loaded surname behind it — and both are now underwriting the same $21 billion number.
The Part Most Coverage Is Missing
Here's the detail that deserves more attention than it's gotten: Trump Jr. isn't just Polymarket's advisor and largest venture backer. He also serves as a strategic adviser to Kalshi — Polymarket's chief rival — a role for which he received shares reportedly worth more than $300,000 last year. That's not a minor footnote. It means the same individual holds a formal advisory relationship with both companies fighting for dominance in an industry currently locked in an existential legal battle over who gets to regulate it. Trump Jr. has said his investment activities are kept separate from his position as a private citizen, and that he holds no formal policy role in his father's administration — a distinction he's been careful to draw publicly, even as the practical overlap between "prediction market investor" and "son of the president whose CFTC is suing states to keep those markets legal" is not one most observers are inclined to ignore.
The Regulatory Fight Both Companies Need to Win
That legal battle is the real reason this funding round matters beyond its headline number. The Commodity Futures Trading Commission argues it holds exclusive federal authority over event contracts — the legal category prediction markets fall under — while more than a dozen states have pushed back with their own lawsuits, arguing that sports and election-related prediction markets are functionally gambling and therefore subject to state law. CFTC Chairman Michael Selig, appointed by President Trump, has been an outspoken supporter of the industry and has backed federal lawsuits against states attempting to impose their own restrictions. Trump Jr. made the industry's preferred framing explicit at a recent event, describing prediction platforms as already subject to "rigorous oversight" at the federal level, "not state attorneys general" — language that maps directly onto the CFTC's own legal position.
Investors of this scale don't typically deploy capital ahead of regulatory clarity unless they're convinced that clarity is coming, and coming in their favor. Both Polymarket and Kalshi are making that bet loudly and publicly, and the amount of institutional capital now backing both companies is itself a signal about how confident sophisticated investors are in the federal-preemption argument prevailing.
Kalshi Isn't Standing Still
Whatever edge Polymarket's political connections provide, Kalshi isn't ceding ground. The rival platform closed its own $1 billion Series F round in May, led by Coatue with participation from Sequoia, Andreessen Horowitz, Paradigm, Morgan Stanley and Ark Invest — a genuinely blue-chip syndicate — at a $22 billion valuation that still edges out Polymarket's new mark. Kalshi's institutional trading volume grew 800% in the six months leading into that raise, with annualized volume reaching $178 billion, a growth rate that suggests real usage is accelerating alongside the fundraising, not just speculative capital chasing a hot sector.
Between the two platforms, prediction markets have now pulled in roughly $2 billion in fresh capital within a matter of months, at valuations sitting within a rounding error of each other. That kind of capital rarely flows into a sector unless investors expect regulatory clarity to eventually break their way — a bet both platforms, and their highest-profile backers, are currently making loudly and in public.
Not Everyone's Convinced
The skepticism isn't limited to state regulators. JPMorgan Chase reportedly ended its direct banking relationship with Polymarket in October 2025 over regulatory concerns, according to Reuters — even as the bank has stayed open to a possible underwriting role should Polymarket eventually pursue an IPO. That's a fairly precise signal from a major bank: not comfortable enough with the current regulatory footing to bank the company day-to-day, but not so skeptical it wants to miss a future public offering either. Polymarket has also faced blocks or restrictions in several countries outside the US, and the House Judiciary Committee has an active inquiry into 1789 Capital's dealings — though that congressional review has not, to date, produced any findings of wrongdoing.
Polymarket's own regulatory history adds another layer worth remembering: the company settled with the CFTC in 2022, paid a $1.4 million fine, and was barred from serving US customers entirely — a restriction it only escaped by acquiring the CFTC-licensed derivatives exchange QCEX, years later. The company currently sitting at a $21 billion valuation was, within the last four years, legally locked out of its largest addressable market.
The Bigger Picture for Investors
None of this is really a story about whether $300 million is a lot of money for a venture fund — it isn't, in the context of a $21 billion company. It's a story about how much institutional and politically connected capital is now betting on a specific regulatory outcome that hasn't actually happened yet. ICE, Coatue, Sequoia, Andreessen Horowitz, and 1789 Capital are not typically categorized as the same kind of investor, and the fact that all of them are underwriting prediction markets at multibillion-dollar valuations simultaneously says something real about where smart money thinks this fight ends. It doesn't, however, guarantee that outcome — state attorneys general haven't dropped their lawsuits, JPMorgan hasn't come back as a banking partner, and the underlying legal question of federal preemption remains genuinely unresolved in court. Prediction markets, fittingly, are themselves a decent tool for handicapping how this plays out. The confidence embedded in a $21 billion price tag is a real data point. It isn't a verdict.
This article is for informational purposes only and does not constitute investment advice.